Exploring the teachings of Jesus? Trying to determine whether God even exists? Or perhaps you’re a committed Jesus-follower looking for practical, relevant perspectives on Christ’s teachings and the Bible? Whatever your thoughts on church, whatever your beliefs about God, these weekly messages are for you.
…
continue reading
Messages from Verve in Las Vegas.
…
continue reading
Join Jenna Gordon, Sarah Stewart-Smith and the rest of the VERVE Books team as we discuss books, ideas, and all things publishing.
…
continue reading
Welcome to Verve Leaf- healthy living for former junk foodies.
…
continue reading
VERVE is a global collective of badass intersectional feminists. Our persisterhood connects women globally online and ‘onland’ through activism, volunteerism, fundraising & awareness campaigns and Prosecco Think Tanks. Each podcast features readings from our blog SHE SAID interspersed with Feminist commentary and information about what we're reading, what we're writing, what gives us hope, what infuriates us, and what we are going to do about it. Resist + Persist + Assist
…
continue reading
Sprudge Co-Founders and Editors Jordan Michelman and Zachary Carlsen explore the world of specialty coffee.
…
continue reading
More and more chemicals are being put into our beauty products, most of which we can’t even pronounce. Every Monday, join Leaza, a licensed cosmetologist and a natural enthusiast, as she talks about natural alternatives for your beauty regimen and natural ways to love yourself. If you are looking for natural ways to jump start your natural beauty routine, want to know more about natural beauty alternatives, or simply want beauty life hacks and tips, then this podcast is for you.
…
continue reading
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.
…
continue reading
This is the Official Site for "Hilliard Guess' SCREENWRITERS' RANT ROOM!" Our host is Hilliard Guess, a WGAw writer, director, TV/Film producer and most recently, the former Director of Development (now producer) at Blue Monday Prods. Hilliard does one-on-one interviews with guests or rotating co-hosts stop by to drop industry bombs in this unfiltered, hilarious podcast series that delivers nuthin’ but REAL TALK… from REAL working writers! Our motto: “Keep it GAME all day!" Support this podc ...
…
continue reading
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
…
continue reading
Music journalist Lily Moayeri talks about her experience interviewing musicians, giving a snapshot of what it is like being on the other side of the digital recorder.
…
continue reading
This podcast aims to bring you a daily summary of most relevant news in Pharma and BioTech world, fully automated and Generated by ChatGPT. If you're interested in similar podcast checkout www.owith.ai
…
continue reading
Understanding music, one band at a time
…
continue reading
The KdT Ventures team takes a deep dive into a specific S-1 filing from a company that is hoping to go public within the life science realm.
…
continue reading
Podcast by 411 Entertainment Management
…
continue reading
Hosted by author-entrepreneur, Koral Dasgupta, the podcast is an attempt to refresh memories, invoke nostalgia and scoop out superb fun stories about the family from various lives. The Great Indian Family is a podcast produced by Ep.Log Media | A Part of Zero Hour Entertainment Live, laugh, enjoy…preferably with your family! www.eplog.media
…
continue reading
More great stuff from the @oasispodcast including- @britpophistory - a monthly show where we journey back in time to relive the Britpop years exactly 30 years on @theRAINPodcast - a regular show where Richard and James review all the news in the world of Rock, Indie and Alternative music Plus in the archives - @1001albumspod - a series of 14 episodes from 2020 where I interviewed creators and fans about the greatest albums of all time (we didn’t get to 1001!!!)
…
continue reading
Unboxing the interdisciplinary art of banding, branding, and business building, Brad Circone reveals the unexpected connections and unique similarities between successful businesses and rock ‘n’ roll bands. What binds them toward success? Brand. Curating the wisdom gained from 30+ years of entertainment, advertising, marketing, and branding expertise, we will hear from rock stars, CEOs, founders, artists, and mavericks, on how they perform the power and principles of brand like no one else.
…
continue reading
A fun, engaging, super unpretentious podcast to help make wine more approachable. It's just fermented juice! Each episode takes a wine topic and breaks it down to be much more manageable, consumable, and approachable. Let's put the days of the overly pretentious snobbery so often associated with wine behind us. Some episodes will have a featured interview where the guest and I talk about wine, what it means in their personal and/or professional life and show the audience that we are all just ...
…
continue reading
1
Party Crasher | Why No Nation Can be Christian
55:22
55:22
Play later
Play later
Lists
Like
Liked
55:22
Was the United States founded as a "Christian nation?" Can any nation be a "Christian nation?" Is the concept of a "Christian nation" any more realistic than a "Christian bicycle" or a "Christian breath mint?" Exploring the teachings of Jesus and the history of "Christian" imperialism, we'll discuss the incompatibility of the way of Jesus and the w…
…
continue reading
1
Basilea grabs FDA nod, Verve halts gene editing trial, Amylyx pulls ALS drug [The good, the bad, the ugly]
3:47
3:47
Play later
Play later
Lists
Like
Liked
3:47
Editor's Review: Week of April 1 Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Basilea Pharmaceutica receives FDA approval for its IV antibiotic The bad — Verve Therapeutics halts gene editing trial, again The ugly — Amylyx removes ALS treatment…
…
continue reading
1
Neurocrine wins FDA nod for 'sprinkle' Ingrezza formulation, Moderna and Metagenomi deal ends, Emergent announces layoffs [The good, the bad, the ugly]
3:37
3:37
Play later
Play later
Lists
Like
Liked
3:37
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Neurocrine wins FDA nod for 'sprinkle' Ingrezza formulation The bad — Moderna, Metagenomi end gene editing collab The ugly — Emergent announces layoffs, closes sites…
…
continue reading
A. Michael Lincoff and C. Michael Gibson discuss the cardiovascular impact of semaglutide in patients with overweight or obesity but without diabetes.By TCTMD
…
continue reading
1
Novartis wins rare cancer pediatric indication, BMS layoffs, McKinsey under fire [The good, the bad, the ugly]
4:26
4:26
Play later
Play later
Lists
Like
Liked
4:26
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Novartis wins rare cancer pediatric indication for Lutathera The bad — BMS unveils cost-saving initiative, layoffs The ugly — McKinsey under fire for alleged role in opioid crisis…
…
continue reading
1
Brewing The Best Decaf In America On The Coffee Sprudgecast
23:32
23:32
Play later
Play later
Lists
Like
Liked
23:32
On the latest episode of the Coffee Sprudgecast, Zachary Carlsen brews BlendIn Coffee Club’s Colombia Los Nogales, the winning 2024 US Brewers Cup Championship coffee (which also happens to be their house decaf coffee!) Weihong Zhang of BlendIn Coffee Club in Houston, Texas, your 2024 United States Brewers Cup champion, took top honors in Rancho Cu…
…
continue reading
"I can't." "I should." "Nobody likes me." "I'm such an idiot." "I'm a dumpster fire." For many of us, the negative talk in our lives is focused less on other people and more on ourselves. While it's healthy to understand our strengths and weaknesses, constantly disparaging ourselves can become a self-fulfilling indictment and a confidence killer. H…
…
continue reading
1
GSK antibiotic hits phase 3 goals, Genentech-Adaptimmune collab ends, Par Pharma recall [The good, the bad, the ugly]
4:10
4:10
Play later
Play later
Lists
Like
Liked
4:10
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — GSK antibiotic hits phase 3 goals in gonorrhea The bad — Genentech ends $3B Adaptimmune T-cell collab The ugly — Par Pharmaceutical recalls Treprostinil injection for potential contamination…
…
continue reading
1
BMS schizophrenia drug shines, Novartis axes jobs, Lilly compounding suit dismissed [The good, the bad, the ugly]
5:01
5:01
Play later
Play later
Lists
Like
Liked
5:01
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — BMS schizophrenia drug shines in phase 3 trial The bad — Novartis to axe 680 jobs The ugly — Lilly compounding suit dismissedBy Pharma Manufacturing
…
continue reading
1
Pharma and Biotech Daily: Insights on FDA Approvals, Drug Performance, and Health Advertising Strategies
2:27
2:27
Play later
Play later
Lists
Like
Liked
2:27
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The FDA recently approved a biosimilar of Stelara from Alvotech and Teva, set to launch early next year. Johnson & Johnson reported mixed sales performance for new multiple myeloma drugs, with Tecvayli sales exceeding expe…
…
continue reading
The way we see and experience others reveals less about them than it does about us. And when we “call it like we see it,” what we say is a reflection of our soul. We can laugh at ridiculous one-star reviews, but don’t we all fall into the trap of spreading negative gossip sometimes? How can adjusting our mindset change the words we say and restore …
…
continue reading
Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.By TCTMD
…
continue reading
1
Pharma and Biotech Daily: Your Source for the Latest in Medical Breakthroughs
1:56
1:56
Play later
Play later
Lists
Like
Liked
1:56
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.## Breakthrough in Cancer TreatmentScientists have discovered a new drug that has shown promising results in treating a rare form of cancer. The drug, which targets specific genetic mutations, has been successful in s…
…
continue reading
1
Pharma and Biotech Daily: Keeping You Informed on the Latest in Healthcare Innovation
2:45
2:45
Play later
Play later
Lists
Like
Liked
2:45
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA new study published in the Journal of Oncology has revealed a groundbreaking discovery in cancer treatment. Researchers have found a novel combination of drugs that have shown signific…
…
continue reading
The Screenwriters Rant Room is taking a 6 week break while Hilliard is away working on a big TV project. Expect us back in mid-May or early June. If you NEED your Rant Room fix, check out the archives - there's almost 500 episodes to enjoy! SHARE, SUBSCRIBE, PROMOTE! Our Motto: "We keep it GAME all day!" Follow Hilliard Guess on X and a…
…
continue reading
1
Pharma and Biotech Daily: Where Innovation Meets Impact
2:17
2:17
Play later
Play later
Lists
Like
Liked
2:17
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentIn a groundbreaking study published in the Journal of Oncology, researchers have discovered a new combination therapy that has shown promising results in treating aggressive forms of can…
…
continue reading
Politics, whether we like them or not, weigh heavy on manufacturing’s future. In case you haven’t heard, it is an election year! Which means, global trade, regulations, immigration, national security and taxation will all be part of the national discourse, and all of those topics touch on manufacturing in one way or another. During this podcast, we…
…
continue reading
1
Biotech Buzz: Funding, M&A, and Regulatory Updates in Pharma World
3:07
3:07
Play later
Play later
Lists
Like
Liked
3:07
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Private biotech funding is on the rise, with venture firms investing in cell therapy developments in cancer care. Century has acquired Clade Therapeutics and raised $60 million through a private placement led by Bain Capita…
…
continue reading
1
Pharma and Biotech Daily: Keeping You Informed on Industry News and Innovations
2:22
2:22
Play later
Play later
Lists
Like
Liked
2:22
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Pfizer is planning to bring an RSV shot to adults aged 18-59, while Boehringer Ingelheim is facing staff layoffs due to biosimilar challenges. Amylyx made a rare move by pulling an ALS drug from the market. On the regulat…
…
continue reading
Hold on to your coffee-loving merchandising trucker hats, because it's time for another action-packed episode of the Coffee Sprudgecast. This week, hosts Zachary Carlsen and Jordan Michelman are all abuzz about the imminent Specialty Coffee Association Expo this weekend in Chicago, Illinois. The comps! The booths! The gallons and gallons of alterna…
…
continue reading
1
Pictures of Lily Podcast (Vintage Edition): Episode 5.82: Electronic: Johnny Marr and Bernard Sumner 2000 Interview
48:34
48:34
Play later
Play later
Lists
Like
Liked
48:34
In the 82nd episode of the Pictures of Lily Podcast, we continue our new format where I share my experience about a specific interview from my 32-year archive. In this episode I revisit interviews I conducted with Johnny Marr and Bernard Sumner at the time of their third Electronic album, Twisted Tenderness being released in the US. The interviews …
…
continue reading
1
Pharma and Biotech Daily: Bringing You the Latest Breakthroughs in Healthcare
1:54
1:54
Play later
Play later
Lists
Like
Liked
1:54
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## Breakthrough in Cancer ResearchScientists have made a significant breakthrough in cancer research, discovering a new potential treatment that targets specific cancer cells without harming healthy cells. This discovery…
…
continue reading
1
The Pharma and Biotech Daily Podcast: Keeping You Informed on the Latest Healthcare Innovations
2:23
2:23
Play later
Play later
Lists
Like
Liked
2:23
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA recent study published in the Journal of Oncology reported a groundbreaking new treatment for certain types of cancer. The treatment, which involves a combination of immunotherapy and …
…
continue reading
Our words hold surprising power to shape our identity, our environment, and our friends. We get to decide whether to wield that power well or to wield it haphazardly. The words we choose, the tone we use, and even our body language can intentionally or inadvertently build up or tear down. So, how do we become people who are filled with words of gra…
…
continue reading
1
Gene Therapy Weekly: Verve's Trial Pause, Ginkgo's Acquisition, and FDA Decisions to Watch
0:54
0:54
Play later
Play later
Lists
Like
Liked
0:54
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.In the latest edition of Gene Therapy Weekly, Verve pauses its base editing trial due to lab abnormalities in a study participant, prompting a shift in strategy. Ginkgo acquires another startup in search of more cell therap…
…
continue reading
1
Pharma and Biotech Weekly: The Latest in Drug Development, M&A, and Regulatory Updates
2:32
2:32
Play later
Play later
Lists
Like
Liked
2:32
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.This week's Commercialization Weekly highlights Bristol Myers' success with a Kras drug trial, Astrazeneca's FDA approval for a rare disease drug acquired from Alexion, FDA approval for Akebia's anemia pill after a previo…
…
continue reading
1
Title: Pharma and Biotech Daily: Your Source for the Latest Industry Updates
2:40
2:40
Play later
Play later
Lists
Like
Liked
2:40
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer ResearchTitle: New Drug Shows Promising Results in Clinical TrialsContent: A new drug has shown promising results in clinical trials for the treatment of a specific type of cancer. Researchers ha…
…
continue reading
Christopher Rajkumar, Rasha Al-Lamee, and C. Michael Gibson discuss this randomized trial of PCI versus a placebo procedure for stable angina.By TCTMD
…
continue reading
1
487: SCOTTY MULLEN - ASSIGNMENT WRITER
1:56:10
1:56:10
Play later
Play later
Lists
Like
Liked
1:56:10
In this episode, Hilliard and Tristan J. Shuler from Road Map Writers sat down in a hilarious and engaging episode that is packed full of game. Our guest this week is little bro, Scotty Mullen, an award-winning writer known for his work with Syfy, Lionsgate, Lifetime, and Tubi. He is also an accomplished casting director and writing mentor. After g…
…
continue reading
1
Pharma and Biotech Daily: Your Daily Dose of What Matters in the Industry
2:06
2:06
Play later
Play later
Lists
Like
Liked
2:06
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentA recent study published in a leading medical journal has shown promising results in a new cancer treatment. Researchers discovered a novel combination of drugs that effectively target s…
…
continue reading
1
[The good, the bad, the ugly] Editor's Review week of March 25
3:45
3:45
Play later
Play later
Lists
Like
Liked
3:45
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Akebia Therapeutics' Vafseo anemia drug The bad — Bristol Myers Squibb's Crohn's disease drug disappoints The ugly — FDA rejects Regeneron Pharmaceuticals lymphoma treatment…
…
continue reading
Celebrated at Easter, Jesus’ resurrection is a central event for Christianity… which means Jesus’ death is also at the center of our faith. But why did Jesus have to die? And what does the answer reveal about God?By Verve City Church
…
continue reading
1
Pharma and Biotech Daily: Keeping You Informed on the Latest Developments
3:11
3:11
Play later
Play later
Lists
Like
Liked
3:11
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Pfizer announces positive results for COVID-19 vaccinePfizer has announced positive results for its COVID-19 vaccine, showing over 90% efficacy in preventing the virus. This is a promising development in the fight agai…
…
continue reading
1
Pharma and Biotech Daily: Your Morning Dose of Industry Updates
2:35
2:35
Play later
Play later
Lists
Like
Liked
2:35
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Biotech veteran Art Krieg has postponed his retirement to start a new drug startup called Zola Therapeutics, focusing on cancer immunotherapies without outside investors. Stoke's shares surged on updated results for their…
…
continue reading
1
Pharma and Biotech Daily: Medicare Covers Novo's Obesity Drug, FDA Approves Italfarmaco's Duchenne Drug, and More!
1:13
1:13
Play later
Play later
Lists
Like
Liked
1:13
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Medicare will now cover Novo's obesity drug for patients with a history of heart disease, while the FDA has approved Italfarmaco's Duchenne drug for all patients over six years old. The Supreme Court is currently consider…
…
continue reading
1
Healthcare Industry Insights: Pharma and Biotech Daily Podcast
1:07
1:07
Play later
Play later
Lists
Like
Liked
1:07
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. In the healthcare industry, there are various issues that are being discussed. The government is scrutinizing the VA EHR deployment, as concerns arise about errors in VA and Oracle EHR integration, impacting patient safety…
…
continue reading
1
The 2024 US Coffee Champs And Songbird Klatch Coffee
29:01
29:01
Play later
Play later
Lists
Like
Liked
29:01
Our coffee podcast program The Coffee Sprudgecast returns with an episode fresh off the US Coffee Champs première partie at Klatch Coffee in Rancho Cucamonga. Over a sun-soaked Southern California weekend, the 2024 United States Barista Champion, Brewers Cup Champion, and Cup Tasters Champion were crowned. Sprudge co-founders and hosts Zachary Carl…
…
continue reading
1
Pharma and Biotech Daily: The Latest in Healthcare Innovation and Market Trends
2:40
2:40
Play later
Play later
Lists
Like
Liked
2:40
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Masimo is planning to spin off its consumer unit two years after acquiring Sound United for its audio brands. In other news, an EU court adviser has sided with Illumina in a dispute that triggered a fine for Grail, Vyaire …
…
continue reading
Jesus was compassionate toward the outcasts of society and brutal toward highly respected religious leaders. He disrupted their religious festivals, called them snakes, and warned their followers to avoid modeling their lives after them. Why does Jesus seem outraged by the most revered of religious leaders rather than the greatest of sinners? Serie…
…
continue reading
1
[The good, the bad, the ugly] Editor's Review week of March 18
5:31
5:31
Play later
Play later
Lists
Like
Liked
5:31
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — Orchard gene therapy wins first FDA nod for rare pediatric disease The bad — Abiomed recalls heart pump instructions due to perforation risks The ugly — J&J files lawsuit against a former employee fo…
…
continue reading
1
486: "ZADOC ANGELL - ECHO LAKE ENTERTAINMENT"
1:20:16
1:20:16
Play later
Play later
Lists
Like
Liked
1:20:16
In this episode, Hilliard and Rene Rodriguez-Lopez (Development Exec at BET+), sat down for a fun, inspiring conversation with Literary Manager ZADOC ANGELL who began his career as a TV Literary Agent at Paradigm, where he worked for seven years. Transitioning to Literary Management 2010, Zadoc joined forces with manager Dave Brown and grew a team …
…
continue reading
1
Pharma and Biotech Daily: Stay Informed on the Latest Breakthroughs and Updates
1:37
1:37
Play later
Play later
Lists
Like
Liked
1:37
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##FDA Approves New Cancer DrugThe FDA has recently approved a new cancer drug that has shown promising results in clinical trials. This drug is expected to provide a much-needed treatment option for patients with certain …
…
continue reading
1
Pharma and Biotech Daily: Stay Informed on Industry Updates and Trends
1:49
1:49
Play later
Play later
Lists
Like
Liked
1:49
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Orchard has set a record-setting price tag of $4.25 million for its gene therapy Lenmeldy, with hopes of convincing insurers to cover it. The FDA panel has backed broader use of J&J and Bristol Myers cell therapies for myel…
…
continue reading
1
Pharma and Biotech Daily: FDA Approvals, Gene Therapy Prices, and More!
0:44
0:44
Play later
Play later
Lists
Like
Liked
0:44
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in Pharma and Biotech world. The FDA panel has approved broader use of J&J and Bristol Myers' cell therapies for myeloma, while Orchard plans to sell the world's priciest gene therapy. Madrigal has won FDA approval for the first drug for Mash, but f…
…
continue reading
1
: Merck's initiative to increase healthcare access in underserved communities
3:54
3:54
Play later
Play later
Lists
Like
Liked
3:54
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##Title: Pfizer announces breakthrough in Alzheimer's treatmentPfizer has recently announced a major breakthrough in the treatment of Alzheimer's disease. The pharmaceutical company has developed a new drug that has shown…
…
continue reading
1
Savage Jesus: Jesus Wasn't Playing Around
45:02
45:02
Play later
Play later
Lists
Like
Liked
45:02
Jesus invites a man to follow him and then seemingly refuses to let him bury his own father. Is Jesus being unreasonable? Does he lack compassion for this man's family? What do we learn about the mission of Jesus as we discover the mindset of Jesus? Series Overview: When we think of Jesus, we often think of his kindness, gentleness, and tenderness.…
…
continue reading
1
Biotech Buzz: IPOs, Cell Therapies, and Industry Insights
1:10
1:10
Play later
Play later
Lists
Like
Liked
1:10
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world. On March 18, 2024, Contineum, a startup formed from a Roche buyout, filed for an IPO. Bluebird, facing financial difficulties, secured $175 million in debt financing. Biotech IPOs are crucial for the industry, and it…
…
continue reading